ArticleBiomedicines2023

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis.

Christos Stergiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.